Interleukin-1 receptor antagonist as therapy for inflammatory disorders

Keyphrases

• Interleukin-1 Receptor Antagonist (IL-1Ra) 100%
• Rheumatoid Arthritis 100%
• Inflammatory Disorders 100%
• Interleukin-1β 66%
• Immune Response 66%
• Anti-cytokine 33%
• Sepsis 33%
• Disease Activity 33%
• Infectious Diseases 33%
• Chronic Inflammatory Diseases 33%
• Clinical Impact 33%
• Clinical Experience 33%
• Therapeutic Strategies 33%
• Septic Shock 33%
• Lack of Efficacy 33%
• Pathologic Processes 33%
• Sepsis Shock 33%
• Inflammatory Diseases 33%
• Endogenous Inhibitor 33%
• Anti-inflammatory Agents 33%
• Conventional Treatment 33%
• Joint Destruction 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Rheumatoid Arthritis 100%
• Interleukin 1 100%
• Interleukin 1 Receptor Blocking Agent 100%
• Inflammatory Arthritis 100%
• Sepsis 66%
• Diseases 66%
• Clinical Study 33%
• Receptor Antagonist 33%
• Physical Disease by Body Function 33%
• Septic Shock 33%
• Antiinflammatory Agent 33%
• Disease Activity 33%
• Inflammatory Disease 33%
• Joint Destruction 33%